These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29452143)

  • 41. A 3-dimensional trimeric β-barrel model for Chlamydia MOMP contains conserved and novel elements of Gram-negative bacterial porins.
    Feher VA; Randall A; Baldi P; Bush RM; de la Maza LM; Amaro RE
    PLoS One; 2013; 8(7):e68934. PubMed ID: 23935908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of a novel affibody molecule targeting Chlamydia trachomatis MOMP.
    Li M; Shi W; Yang J; Wang Q; Dong H; Chen J; Zhang L; Zhu S
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1477-1487. PubMed ID: 33521848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of recombinant fragments of the major outer-membrane protein of Chlamydia trachomatis: their potential as subunit vaccines.
    Conlan JW; Ferris S; Clarke IN; Ward ME
    J Gen Microbiol; 1990 Oct; 136(10):2013-20. PubMed ID: 1702826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
    Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
    Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.
    Zheng Y; Zhao WM; Wang H; Zhou YB; Luan Y; Qi M; Cheng YZ; Tang W; Liu J; Yu H; Yu XP; Fan YJ; Yang X
    Biochem Cell Biol; 2007 Apr; 85(2):218-26. PubMed ID: 17534403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis.
    Batteiger BE; Rank RG; Bavoil PM; Soderberg LS
    J Gen Microbiol; 1993 Dec; 139(12):2965-72. PubMed ID: 7510322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens.
    Madico G; Gursky O; Fairman J; Massari P
    Vaccines (Basel); 2017 Dec; 6(1):. PubMed ID: 29295593
    [No Abstract]   [Full Text] [Related]  

  • 49. Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis.
    Stagg AJ; Elsley WA; Pickett MA; Ward ME; Knight SC
    Immunology; 1993 May; 79(1):1-9. PubMed ID: 8099564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is a Chlamydia vaccine a reality?
    Christiansen G; Birkelund S
    Best Pract Res Clin Obstet Gynaecol; 2002 Dec; 16(6):889-900. PubMed ID: 12473289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
    Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
    J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
    Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF
    Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Designing and in Silico Analysis of PorB Protein from Chlamydia Trachomatis for Developing a Vaccine Candidate.
    Pourhajibagher M; Bahador A
    Drug Res (Stuttg); 2016 Sep; 66(9):479-483. PubMed ID: 27409330
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification of surface-exposed components of MOMP of Chlamydia trachomatis serovar F.
    Wang Y; Berg EA; Feng X; Shen L; Smith T; Costello CE; Zhang YX
    Protein Sci; 2006 Jan; 15(1):122-34. PubMed ID: 16322562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
    Andrew DW; Hafner LM; Beagley KW; Timms P
    J Reprod Immunol; 2011 Sep; 91(1-2):9-16. PubMed ID: 21856018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of the Chlamydia trachomatis immunodominant antigen Pgp3.
    Galaleldeen A; Taylor AB; Chen D; Schuermann JP; Holloway SP; Hou S; Gong S; Zhong G; Hart PJ
    J Biol Chem; 2013 Jul; 288(30):22068-79. PubMed ID: 23703617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel chimeric MOMP antigen expressed in Escherichia coli, Arabidopsis thaliana, and Daucus carota as a potential Chlamydia trachomatis vaccine candidate.
    Kalbina I; Wallin A; Lindh I; Engström P; Andersson S; Strid K
    Protein Expr Purif; 2011 Dec; 80(2):194-202. PubMed ID: 21903168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
    Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
    Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
    J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    Nyari S; Khan SA; Rawlinson G; Waugh CA; Potter A; Gerdts V; Timms P
    PLoS One; 2018; 13(6):e0200112. PubMed ID: 29953523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.